Scarica l'app Stockscreener
99.72
1.16%
-1.17
Dopo l'orario di chiusura:
99.81
0.09
+0.09%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$100.89
Aprire:
$101.4
Volume 24 ore:
15.96M
Relative Volume:
1.22
Capitalizzazione di mercato:
$247.51B
Reddito:
$63.90B
Utile/perdita netta:
$19.05B
Rapporto P/E:
13.19
EPS:
7.5596
Flusso di cassa netto:
$13.05B
1 W Prestazione:
-4.87%
1M Prestazione:
+18.17%
6M Prestazione:
+28.47%
1 anno Prestazione:
-3.70%
Intervallo 1D:
$99.19
$102.09
Intervallo di 1 settimana:
$99.19
$105.68
Portata 52W:
$73.31
$105.84
Merck Co Inc Stock (MRK) Company Profile
Nome
Merck Co Inc
Settore
Industria
Telefono
908-740-4000
Indirizzo
126 EAST LINCOLN AVENUE, RAHWAY, NJ
Confronta MRK con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MRK
Merck Co Inc
|
99.72 | 250.41B | 63.90B | 19.05B | 13.05B | 7.5596 |
|
LLY
Lilly Eli Co
|
1,010.31 | 907.99B | 59.42B | 18.41B | 6.44B | 20.22 |
|
JNJ
Johnson Johnson
|
201.93 | 487.83B | 92.15B | 25.12B | 20.46B | 10.36 |
|
ABBV
Abbvie Inc
|
226.08 | 404.22B | 59.64B | 2.36B | 19.68B | 1.3253 |
|
NVS
Novartis Ag Adr
|
132.16 | 254.11B | 54.45B | 14.42B | 17.15B | 7.333 |
Merck Co Inc Stock (MRK) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-11-24 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2025-11-13 | Iniziato | Scotiabank | Sector Outperform |
| 2025-10-13 | Ripresa | Citigroup | Neutral |
| 2025-09-17 | Downgrade | Berenberg | Buy → Hold |
| 2025-05-14 | Downgrade | Citigroup | Buy → Neutral |
| 2025-04-22 | Iniziato | Cantor Fitzgerald | Neutral |
| 2025-02-18 | Downgrade | Deutsche Bank | Buy → Hold |
| 2025-02-10 | Downgrade | TD Cowen | Buy → Hold |
| 2025-01-08 | Downgrade | Truist | Buy → Hold |
| 2024-12-20 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| 2024-12-10 | Ripresa | BofA Securities | Buy |
| 2024-12-04 | Aggiornamento | HSBC Securities | Hold → Buy |
| 2024-11-15 | Iniziato | Wolfe Research | Peer Perform |
| 2024-11-11 | Downgrade | Daiwa Securities | Buy → Neutral |
| 2024-10-17 | Iniziato | Bernstein | Mkt Perform |
| 2024-03-11 | Downgrade | Societe Generale | Hold → Sell |
| 2024-01-04 | Aggiornamento | TD Cowen | Market Perform → Outperform |
| 2023-11-09 | Iniziato | Deutsche Bank | Buy |
| 2023-10-27 | Aggiornamento | BMO Capital Markets | Market Perform → Outperform |
| 2023-10-20 | Aggiornamento | UBS | Neutral → Buy |
| 2023-07-14 | Iniziato | HSBC Securities | Hold |
| 2023-04-13 | Aggiornamento | Citigroup | Neutral → Buy |
| 2023-03-28 | Downgrade | Societe Generale | Buy → Hold |
| 2023-03-13 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2023-03-06 | Iniziato | Jefferies | Buy |
| 2023-02-22 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2023-01-04 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2022-11-18 | Iniziato | Credit Suisse | Outperform |
| 2022-10-10 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2022-09-14 | Aggiornamento | Berenberg | Hold → Buy |
| 2022-07-06 | Aggiornamento | Daiwa Securities | Neutral → Buy |
| 2022-06-06 | Ripresa | SVB Leerink | Outperform |
| 2022-04-06 | Ripresa | Morgan Stanley | Equal-Weight |
| 2021-12-17 | Iniziato | Goldman | Buy |
| 2021-12-16 | Iniziato | Daiwa Securities | Neutral |
| 2021-12-13 | Downgrade | UBS | Buy → Neutral |
| 2021-12-09 | Iniziato | Wells Fargo | Overweight |
| 2021-12-07 | Downgrade | Guggenheim | Buy → Neutral |
| 2021-11-29 | Downgrade | Citigroup | Buy → Neutral |
| 2021-11-19 | Iniziato | BMO Capital Markets | Market Perform |
| 2021-11-01 | Aggiornamento | Argus | Hold → Buy |
| 2021-09-07 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2021-07-27 | Ripresa | Truist | Buy |
| 2021-05-20 | Downgrade | Argus | Buy → Hold |
| 2021-04-07 | Ripresa | RBC Capital Mkts | Sector Perform |
| 2020-11-10 | Ripresa | Bernstein | Outperform |
| 2020-09-29 | Iniziato | Berenberg | Hold |
| 2020-08-03 | Aggiornamento | Goldman | Neutral → Buy |
| 2020-06-12 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2020-02-27 | Iniziato | Barclays | Overweight |
| 2020-01-07 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2019-10-17 | Ripresa | BofA/Merrill | Neutral |
| 2019-08-16 | Iniziato | SVB Leerink | Outperform |
| 2019-07-03 | Iniziato | Mizuho | Buy |
| 2019-05-28 | Iniziato | Goldman | Neutral |
| 2019-05-13 | Aggiornamento | Atlantic Equities | Neutral → Overweight |
| 2018-10-16 | Reiterato | Citigroup | Buy |
| 2018-10-09 | Ripresa | Guggenheim | Buy |
| 2018-04-23 | Aggiornamento | Goldman | Neutral → Buy |
| 2018-04-17 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2018-04-05 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2018-03-12 | Aggiornamento | Leerink Partners | Mkt Perform → Outperform |
| 2018-02-14 | Reiterato | Leerink Partners | Mkt Perform |
| 2018-02-07 | Reiterato | Morgan Stanley | Equal-Weight |
| 2018-01-16 | Aggiornamento | SunTrust | Hold → Buy |
Mostra tutto
Merck Co Inc Borsa (MRK) Ultime notizie
Do These 3 Healthcare Stocks Need a Checkup? - The Motley Fool
Trek Financial LLC Decreases Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
M Holdings Securities Inc. Boosts Stake in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Kennedy Capital Management LLC - MarketBeat
Guggenheim Adjusts Price Target on Merck & Co. to $122 From $104, Maintains Buy Rating - marketscreener.com
Amundi Buys 3,454,941 Shares of Merck & Co., Inc. $MRK - MarketBeat
Beutel Goodman & Co Ltd. Acquires 679,339 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Trading Down 1.4%What's Next? - MarketBeat
Merck & Co. Closes $7 Billion Notes Offering - TipRanks
Merck & Co., Inc. (MRK) Stock: Gains FDA Nod for New Cattle Antiparasitic - CoinCentral
Scotiabank Issues Positive Forecast for Merck & Co., Inc. (NYSE:MRK) Stock Price - MarketBeat
FDA Conditionally Approves Merck Animal Health's EXZOLT™ CATTLE-CA1 for the Prevention and Treatment - pharmiweb.com
Merck & Co., Inc. (MRK): A Bull Case Theory - Insider Monkey
Merck (NYSE: MRK) gets FDA conditional OK for EXZOLT CATTLE-CA1 vs New World screwworm - Stock Titan
Scotiabank Adjusts Price Target on Merck & Co to $120 From $105, Maintains Sector Outperform Rating - marketscreener.com
Merck & Co., Inc. $MRK Shares Bought by Guggenheim Capital LLC - MarketBeat
First Trust Advisors LP Has $399.74 Million Stock Position in Merck & Co., Inc. $MRK - MarketBeat
CW Advisors LLC Reduces Stock Position in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Baird Financial Group Inc. - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Shares Up 1.3% on Analyst Upgrade - MarketBeat
Analysts Conflicted on These Healthcare Names: Merck & Company (MRK), Alibaba Health Information Technology (OtherALBHF) and Janux Therapeutics Inc (JANX) - The Globe and Mail
River Wealth Advisors LLC Boosts Stake in Merck & Co., Inc. $MRK - MarketBeat
Invesco Ltd. Has $1.35 Billion Stake in Merck & Co., Inc. $MRK - MarketBeat
Merck (MRK) Stock on December 2, 2025: Dividend Hike, FDA Wins and Fresh Wall Street Targets - ts2.tech
The Goldman Sachs Group Boosts Merck & Co., Inc. (NYSE:MRK) Price Target to $120.00 - MarketBeat
Transcript : Merck & Co., Inc. Presents at Evercore 8th Annual Healthcare Conference, Dec-02-2025 09 - marketscreener.com
Westerkirk Capital Inc. Makes New $2.64 Million Investment in Merck & Co., Inc. $MRK - MarketBeat
Isthmus Partners LLC Makes New $1.03 Million Investment in Merck & Co., Inc. $MRK - MarketBeat
Sio Capital Management LLC Has $13.77 Million Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
M&T Bank Corp Decreases Position in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co Files For Seven- Part Notes Offering Of Up To $7.5 Billion- SEC Filing - TradingView
Merck & Co., Inc. (NYSE:MRK) Shares Down Following Recent Session Drop - Kalkine Media
Merck & Co., Inc. $MRK Shares Acquired by Arrowstreet Capital Limited Partnership - MarketBeat
Merck Wants Fed. Circ. Redo On Decision Backing Axed IP - Law360
Merck & Co., Inc. (NYSE:MRK) Stock Price Down 2.9%Here's Why - MarketBeat
Merck Kicks Off US Dollar Bond Sale to Help Fund Cidara Deal - Bloomberg.com
A Look Into Merck & Co Inc's Price Over Earnings - Benzinga
Merck seeks up to US$8 bil in US bond sale tied to Cidara deal — Bloomberg - The Edge Malaysia
VestGen Advisors LLC Boosts Holdings in Merck & Co., Inc. $MRK - MarketBeat
Form 424B5 Merck & Co., Inc. - StreetInsider
Merck Showcases Data For Alzheimer's Disease Candidates Mk-2214 And Mk-1167 At Ctad 2025 - TradingView
OMERS ADMINISTRATION Corp Boosts Stock Position in Merck & Co., Inc. $MRK - MarketBeat
TradeLink Capital LLC Takes Position in Merck & Co., Inc. $MRK - MarketBeat
Shelton Capital Management Acquires 22,024 Shares of Merck & Co., Inc. $MRK - MarketBeat
Legacy Capital Wealth Partners LLC Has $314,000 Holdings in Merck & Co., Inc. $MRK - MarketBeat
Merck (NYSE: MRK) gets FDA Fast Track for MK-2214, shares human Alzheimer’s data at CTAD - Stock Titan
Loomis Sayles & Co. L P Has $18.33 Million Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Quadrature Capital Ltd Trims Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Stock Position Lessened by Northwestern Mutual Wealth Management Co. - MarketBeat
Distillate Capital Partners LLC Sells 58,061 Shares of Merck & Co., Inc. $MRK - MarketBeat
Fisher Asset Management LLC Boosts Stake in Merck & Co., Inc. $MRK - MarketBeat
Merck Co Inc Azioni (MRK) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.20%
1.28%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):